International Patent: OLIGONUCLEOTIDE MODULATORS FOR REGULATING MICROTUBULE-ASSOCIATED PROTEIN TAU GENE EXPRESSION

GENEVA, Aug. 21 -- RACTIGEN THERAPEUTICS filed a patent application (CN2026/079508) for “OLIGONUCLEOTIDE MODULATORS FOR REGULATING MICROTUBULE-ASSOCIATED PROTEIN TAU GENE EXPRESSION”. With publication no. WO/2026/171281, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....